article thumbnail

EC approves first-line ovarian cancer treatment

European Pharmaceutical Review

The small molecule treatment is indicated as a first-line maintenance treatment for individuals with advanced ovarian cancer regardless of their BRCA mutation status, who have responded to first-line platinum-based chemotherapy. ” The EC based its approval the Phase III ATHENA-MONO study results.

article thumbnail

Daiichi Sankyo grabs first approval for blood cancer drug Ezharmia

pharmaphorum

The Ministry of Health, Labour and Welfare (MHLW) in Japan has cleared Ezharmia (valemetostat tosylate) based on the results of an open-label phase 2 trial which revealed a 48% overall response rate with the drug in previously-treated ATL patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

OTC antiemetic medications: Relief for nausea and vomiting

The Checkup by Singlecare

Antiemetics may also reduce radiation-associated or chemotherapy-induced nausea resulting from cancer treatment. Be sure to follow the dosing instructions on the label for your child’s age. Antiemetic side effects Most OTC antiemetics are well-tolerated and safe if taken according to the labeled instructions.

Dosage 97
article thumbnail

Can you take too much melatonin?

The Checkup by Singlecare

There’s also some evidence that high doses of melatonin given to cancer patients in conjunction with treatment like chemotherapy may help shrink tumors and improve survival rates. Taking too much melatonin can be dangerous,” Dr. Seitz says, “so it’s important to follow the dosage instructions on the product label.”

Dosage 98